No significant improvement of outcomes with EPA in COVID-19 - PACE-CME

No significant improvement of outcomes with EPA in COVID

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

A recap of a study on reversal of the effect of P2Y12i
A recap of a study on reversal of the effect of P2Y12i
AHA 2021
A recap of a study on reversal of the effect of P2Y12i
- Deepak Bhatt, MD
FXIa inhibitor as a promising new anticoagulant drug
FXIa inhibitor as a promising new anticoagulant drug
AHA 2021
FXIa inhibitor as a promising new anticoagulant drug
- Prof. Jeffrey Weitz, MD
What is the effect of low-dose aspirin on dementia risk in T2DM?
What is the effect of low-dose aspirin on dementia risk in T2DM?
AHA 2021
What is the effect of low-dose aspirin on dementia risk in T2DM?
- Prof. Jane Armitage
Ambitious project on use of non-physician providers to control BP
Ambitious project on use of non-physician providers to control BP
AHA 2021
Ambitious project on use of non-physician providers to control BP
- Prof. Keith Ferdinand, MD